Ortho Tri-Cyclen Pediatric Precaution Data Will Be Added To Label
Executive Summary
Ortho-McNeil is changing labeling for Ortho Tri-Cyclen to include information from its pediatric exclusivity study showing lack of significant effect on low mineral bone density in anorexic adolescent females
You may also be interested in...
BPCA Adverse Event Reports To Be Presented According To Three-Tier System
FDA has developed a three-tier system for its presentations of pediatric drug adverse event reports to its Pediatric Advisory Committee, as mandated by the Best Pharmaceuticals for Children Act
BPCA Adverse Event Reports To Be Presented According To Three-Tier System
FDA has developed a three-tier system for its presentations of pediatric drug adverse event reports to its Pediatric Advisory Committee, as mandated by the Best Pharmaceuticals for Children Act
Concerta Adverse Events Update On “Drug Watch” Web Site Advised By Cmte.
FDA should consider posting concerns about psychiatric and cardiovascular adverse events with Johnson & Johnson's Concerta and other methylphenidate products on the agency's upcoming "Drug Watch" website, members of FDA's Pediatric Advisory Committee said